Leuprolide Acetate Kit
Product Images NDC 55150-478

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 55150-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Leuprolide Fig1)

An instructional illustration showing a hand holding a syringe. The syringe is being filled or prepared, indicating a step related to injection or medication administration. No text or specific product details are visible.*

FDA Label Image

Figure J (Leuprolide Fig10)

An instructional illustration showing a hand holding a syringe or injection device being prepared for an injection into another hand, suggesting the process of administering a dose of the product.*

FDA Label Image

Figure K (Leuprolide Fig11)

An instructional illustration showing a syringe held by one hand injecting a substance into the skin while the other hand gently presses down on the injection site, indicating the proper technique for administering an injection.*

FDA Label Image

Figure L (Leuprolide Fig12)

An instructional illustration showing a hand inserting a syringe into a round opening on top of a square container, likely depicting a step in the use of a medical kit. The container has a rectangular label on the front side. The image is black and white with a sketch style.*

FDA Label Image

Leuprolide-figure-13 (Leuprolide Fig13)

Label for Leuprolide Acetate Injection kit, containing 14 mg per 2.8 mL (1 mg/0.2 mL) for subcutaneous injection. The product is a sterile, multiple-dose vial labeled for human prescription use. It is manufactured in India for AuroMedics Pharma LLC and distributed by Eugia US LLC, with NDC 55150-338-01.*

FDA Label Image

Leuprolide-figure-14 (Leuprolide Fig14)

Packaging label for Leuprolide Acetate Injection 14 mg per 2.8 mL (1 mg/0.2 mL) for subcutaneous injection, sterile, in a 2.8 mL multiple-dose vial. The label shows product NDC 55150-338-01 and mentions distribution by Auro Medics Pharma LLC. Storage and dosage information is provided, along with a barcode and product warnings.*

FDA Label Image

Package Label-principal Display Panel-14 mg Per 2.8 mL (1 mg/0.2 mL) (Container-Carton (14 Days Kit))

Packaging label for LEUPROLIDE ACETATE Injection 14 mg per 2.8 mL (1 mg/0.2 mL) 14 Day Patient Administration Kit by Eugia US LLC. The kit is for subcutaneous injection and labeled sterile. The package includes one 2.8 mL vial, 14 disposable syringes with fixed needles, 28 alcohol swabs, and prescribing information. Distributed by AuroMedics Pharma LLC.*

FDA Label Image

Figure B (Leuprolide Fig2)

An illustration showing a pair of hands being washed under a running faucet. Water is flowing over the hands, indicating handwashing or rinsing.*

FDA Label Image

Figure C (Leuprolide Fig3)

An instructional illustration showing a person's finger pressing down on the top of a vial, likely to demonstrate how to open or activate the vial's seal or cap. No specific text or branding is visible.*

FDA Label Image

Figure D (Leuprolide Fig4)

An instructional illustration showing a person's hands preparing a syringe with medication, demonstrating the process of drawing liquid from a vial or ampule. This image is likely part of administration or preparation instructions for a drug kit.*

FDA Label Image

Figure E (Leuprolide Fig5)

An instructional illustration showing a hand holding a syringe, with an arrow indicating the removal of the needle cap from the syringe tip. The image depicts the step of preparing the syringe for injection by taking off the protective cover.*

FDA Label Image

Figure F (Leuprolide Fig6)

A black and white illustration showing a close-up of hands preparing a syringe with a needle. The image appears instructional, likely demonstrating how to handle or use an injection device, relevant as a kit component for Leuprolide Acetate.*

FDA Label Image

Figure G (Leuprolide Fig7)

An instructional illustration showing hands drawing a liquid into a syringe from a vial, likely demonstrating preparation of an injectable medication. The vial is held with one hand while the other hand draws the syringe plunger upward.*

FDA Label Image

Figure H (Leuprolide Fig8)

An instructional black-and-white illustration depicting a close-up view of a hand holding a vial and attaching or preparing a syringe. The syringe is aligned with the vial's rubber stopper, suggesting the drawing demonstrates how to draw medication from the vial into the syringe.*

FDA Label Image

Figure I (Leuprolide Fig9)

An instructional black-and-white illustration showing hands drawing liquid from a vial into a syringe, demonstrating the preparation of an injectable medication, consistent with use in a medication kit such as LEUPROLIDE ACETATE.*

FDA Label Image

Chemical Structure (Leuprolide Str)

Chemical structure of leuprolide acetate depicting its molecular configuration with labeled atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.